DOCSLIB.ORG

Loss-Of-Function DNA Sequence Variant in the CLCNKA Chloride Channel Implicates the Cardio-Renal Axis in Interindividual Heart Failure Risk Variation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation Thomas P. Cappolaa,1, Scot J. Matkovichb, Wei Wangc, Derek van Boovenb, Mingyao Lid, Xuexia Wangd, Liming Qud, Nancy K. Sweitzere, James C. Fangf, Muredach P. Reillya, Hakon Hakonarsong, Jeanne M. Nerbonnec, and Gerald W. Dorn IIb,1 aPenn Cardiovascular Institute, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; bCenter for Pharmacogenomics, Department of Medicine, and cDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, MO 63110; dCenter for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; eDivision of Cardiovascular Medicine, University of Wisconsin, Madison, WI 53792; fDivision of Cardiovascular Medicine, Case Western Reserve University, Cleveland, OH 44106; and gCenter for Applied Genomics, Children’s Hospital of Philadelphia, Philadelphia, PA 19104 Edited* by Jonathan G. Seidman, Harvard Medical School, Boston, MA, and approved December 20, 2010 (received for review November 22, 2010) Common heart failure has a strong undefined heritable component. The Institute for Translational Medicine and Therapeutics/ Two recent independent cardiovascular SNP array studies identified Broad Institute/Candidate-gene Association Resource (IBC) con- a common SNP at 1p36 in intron 2 of the HSPB7 gene as being asso- sortium developed a high-density SNP cardiovascular subgenome ciated with heart failure. HSPB7 resequencing identified other risk array to complement genome-wide platforms in heart disease (13). alleles but no functional gene variants. Here, we further show no Using this array, we previously identified in two US Caucasian heart effect of the HSPB7 SNP on cardiac HSPB7 mRNA levels or splicing, failure referral populations a heart failure risk locus on chromo- suggesting that the SNP marks the position of a functional variant in some 1p36 (rs1739843), within the cardiovascular heat shock pro- another gene. Accordingly, we used massively parallel platforms to tein gene HSPB7 (14). A European consortium using the IBC array resequence all coding exons of the adjacent CLCNKA gene, which recently reported that the identical variant was their strongest ge- K K CLCNKA encodes the a renal chloride channel (ClC- a). Of 51 exonic netic predictor of nonfamilial dilated cardiomyopathy (15). Thus, MEDICAL SCIENCES variants identified, one SNP (rs10927887, encoding Arg83Gly) was taken together, rs1739843 has been linked with heart failure in six common, in linkage disequilibrium with the heart failure risk SNP in independent populations on two continents, establishing it as a HSPB7, and associated with heart failure in two independent Cauca- bona fide heart failure risk variant. rs1739843 occurs in intron 2 sian referral populations (n = 2,606 and 1,168; combined P =2.25× of HSPB7 and has no predicted affect on its protein sequence −6 10 ). Individual genotyping of rs10927887 in the two study popula- or function. Accordingly, we previously resequenced the entire tions and a third independent heart failure cohort (combined HSPB7 gene to screen for nearby functional variants (16). Al- n = 5,489) revealed an additive allele effect on heart failure risk though these experiments further confirmed the rs1739843 as- that is independent of age, sex, and prior hypertension (odds ratio = sociation and revealed 11 additional heart failure-associated P × −7 1.27 per allele copy; =8.3 10 ). Functional characterization of SNPs in tight linkage disequilibrium, the additional HSPB7 SNPs K recombinant wild-type Arg83 and variant Gly83 ClC- a chloride chan- were also intronic or synonymous. As such, the causative gene ≈ nel currents revealed 50% loss-of-function of the variant channel. variant(s) remain unknown, suggesting either that rs1739843 fi fi These ndings identify a common, functionally signi cant genetic marks an expression quantitative trait locus (eQTL) that modifies CLCNKA risk factor for Caucasian heart failure. The variant risk allele, HSPB7 expression (17) or that it marks the position of a geneti- HSPB7 telegraphed by linked variants in the adjacent gene, uncovers cally linked functional variant located outside of HSPB7. a previously overlooked genetic mechanism affecting the cardio- Here we demonstrate that there is no association between renal axis. rs1739843 genotype and HSPB7 mRNA expression levels or splicing in human myocardium, making an eQTL mechanism cardiomyopathy | genetic association unlikely. For this reason, we resequenced the coding exons of the neighboring gene, CLCNKA, which is within the same linkage- he lifetime risk of developing heart failure is estimated at one disequilibrium block as HSPB7.Of51CLCNKA sequence var- Tin five (1, 2). Although rare familial cardiomyopathies can iants identified, rs10927887 (encoding Arg83Gly) is positively lead to heart failure that is almost entirely attributable to genetic associated with heart failure risk in three independent Caucasian factors, common heart failure has a smaller, poorly defined her- heart failure populations. Functional analysis shows the Gly83 itable component. Framingham Heart Study data show that pa- variant channel to exhibit markedly abnormal chloride currents, rental heart failure confers a 70% greater disease risk than in suggesting that this common loss of function variant in CLCNKA individuals without a family history (3). Cardiac hypertrophy that at 1p36 confers heart failure risk in Caucasians and accounts for predisposes to heart failure is also heritable, suggesting that un- derlying genetic variation contributes to interindividual variability in heart failure risk (4). A fraction of common heart failure may Author contributions: T.P.C., J.M.N., and G.W.D. designed research; T.P.C., S.J.M., W.W., be due to unrecognized monogenic cardiomyopathy (5), but most D.v.B., M.L., X.W., L.Q., N.K.S., J.C.F., M.P.R., H.H., J.M.N., and G.W.D. performed research; T.P.C., S.J.M., W.W., D.v.B., M.L., N.K.S., J.C.F., M.P.R., H.H., J.M.N., and G.W.D. contributed cases are explained by multiple interacting environmental and as- new reagents/analytic tools; T.P.C., S.J.M., W.W., D.v.B., M.L., X.W., L.Q., M.P.R., H.H., J.M.N., yet unidentified genetic susceptibility factors. Previous efforts to and G.W.D. analyzed data; and T.P.C., S.J.M., H.H., and G.W.D. wrote the paper. identify genetic risk variants uncovered a rare combination of The authors declare no conflict of interest. adrenergic receptor polymorphisms that increases heart failure *This Direct Submission article had a prearranged editor. susceptibility 10-fold among African Americans (6), although this Freely available online through the PNAS open access option. particular combination of risk alleles has not yet been replicated 1To whom correspondence may be addressed. E-mail: [email protected] (7, 8). A few population-based cohort studies have implicated or [email protected]. – genomic regions in heart failure risk (9 11) or mortality (12), but This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. specific causative risk alleles are still unknown. 1073/pnas.1017494108/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1017494108 PNAS Early Edition | 1of6 Downloaded by guest on September 23, 2021 the previously described association between some HSPB7 SNPs variants marked heart failure risk alleles within the broader ge- and heart failure. netic region. Accordingly, we resequenced all 19 coding exons and intron–exon boundaries of the adjacent CLCNKA gene in Results 1,742 DNA samples from the Cincinnati Heart Failure Study rs1739843 Is Not Associated with Altered Myocardial HSPB7 Expression (18, 19). (Detailed clinical characteristics of the study pop- or Splicing. The rs1739843 intronic HSPB7 SNP has been associated ulations are in Table S1.) Polymorphism screening by pooled with heart failure in multiple independent cohorts. Neither it nor resequencing identified 51 nonprivate exonic CLCNKA SNPs other linked polymorphisms alter protein coding. To examine (nine in dbSNP and 42 previously unreported; 11 synonymous whether this SNP might instead confer HSPB7 dysfunction by al- and 40 nonsynonymous; Table S2). Only seven of these SNPs tering transcription, we measured HSPB7 mRNA levels from human (five nonsynonymous) are common, defined as having an allele left-ventricular heart specimens of 111 Caucasian heart failure sub- frequency of ≥0.05. Thus, the CLCNKA gene exhibits limited jects genotyped for rs1739843. Using microarrays, we found no dif- polymorphic variability. ference in HSPB7 expression across rs1739843 genotypes, and we To determine whether CLCNKA polymorphisms were associ- verified this finding using RT–quantitative PCR (RT-qPCR) (Fig. ated with heart failure, allele frequencies for the 51 SNPs were 1A). HSPB7 exon expression revealed identical splicing patterns compared between 1,117 Caucasian heart failure cases and 625 regardless of rs1739843 genotype (Fig. 1B). Thus, the association unaffected controls. Nine SNPs (seven nonsynonymous) had between rs1739843 and heart failure risk is unlikely to be caused by significant associations with heart failure (P < 0.001, corre- an eQTL mechanism or by alterations in HSPB7 splicing. sponding to a Bonferroni-adjusted P < 0.05). In all but one in- stance allele frequencies for these SNPs were <0.05, whereas that A Common Nonsynonymous CLCNKA SNP Is Associated with Systolic for the marker HSPB7 SNP was ≈0.5 (14, 16). However, the allele Heart Failure. HapMap data reveal the HSPB7 locus on 1p36 to be frequency of rs10927887 was ≈0.50 in controls and ≈0.57 in heart − an area of high linkage disequilibrium (Fig. 2A). Because the failure cases (P = 7.09 × 10 5; Table S2), which is similar to the HSPB7 heart failure-associated SNPs do not alter protein coding marker HSPB7 SNP. This CLCNKA variant encodes a change HSPB7 or cardiac gene expression, we hypothesized that the risk from Arg to Gly at amino acid 83 (exon 3) of the renal ClC-Ka chloride channel (Fig.
Recommended publications
  • Screening and Identification of Key Biomarkers in Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis

    Screening and Identification of Key Biomarkers in Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis

    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Clear cell renal cell carcinoma (ccRCC) is one of the most common types of malignancy of the urinary system. The pathogenesis and effective diagnosis of ccRCC have become popular topics for research in the previous decade. In the current study, an integrated bioinformatics analysis was performed to identify core genes associated in ccRCC. An expression dataset (GSE105261) was downloaded from the Gene Expression Omnibus database, and included 26 ccRCC and 9 normal kideny samples. Assessment of the microarray dataset led to the recognition of differentially expressed genes (DEGs), which was subsequently used for pathway and gene ontology (GO) enrichment analysis.
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
  • Mutations of BSND Can Cause Nonsyndromic Deafness Or Bartter Syndrome

    Mutations of BSND Can Cause Nonsyndromic Deafness Or Bartter Syndrome

    REPORT Molecular Basis of DFNB73: Mutations of BSND Can Cause Nonsyndromic Deafness or Bartter Syndrome Saima Riazuddin,1,2,7 Saima Anwar,3,7 Martin Fischer,4 Zubair M. Ahmed,1,2 Shahid Y. Khan,3 Audrey G.H. Janssen,4 Ahmad U. Zafar,3 Ute Scholl,4 Tayyab Husnain,3 Inna A. Belyantseva,1 Penelope L. Friedman,5 Sheikh Riazuddin,3 Thomas B. Friedman,1 and Christoph Fahlke4,6,* BSND encodes barttin, an accessory subunit of renal and inner ear chloride channels. To date, all mutations of BSND have been shown to cause Bartter syndrome type IV, characterized by significant renal abnormalities and deafness. We identified a BSND mutation (p.I12T) in four kindreds segregating nonsyndromic deafness linked to a 4.04-cM interval on chromosome 1p32.3. The functional consequences of p.I12T differ from BSND mutations that cause renal failure and deafness in Bartter syndrome type IV. p.I12T leaves chloride channel function unaffected and only interferes with chaperone function of barttin in intracellular trafficking. This study provides functional data implicating a hypomorphic allele of BSND as a cause of apparent nonsyndromic deafness. We demonstrate that BSND mutations with different functional consequences are the basis for either syndromic or nonsyndromic deafness. Antenatal Bartter syndrome comprises a genetically and PKDF067, were found to be segregating the c.35T>C allele phenotypically heterogeneous group of salt-losing ne- of BSND resulting in a substitution of threonine for a highly phropathies.1,2 Affected individuals with Bartter syndrome conserved isoleucine (p.I12T) (Figure 2B). In a fourth type IV (MIM 602522) suffer from increased urinary family, PKDF815, 25 affected members enrolled in this chloride excretion, elevated plasma renin activity, hyperal- study.
  • Inherited Renal Tubulopathies—Challenges and Controversies

    Inherited Renal Tubulopathies—Challenges and Controversies

    G C A T T A C G G C A T genes Review Inherited Renal Tubulopathies—Challenges and Controversies Daniela Iancu 1,* and Emma Ashton 2 1 UCL-Centre for Nephrology, Royal Free Campus, University College London, Rowland Hill Street, London NW3 2PF, UK 2 Rare & Inherited Disease Laboratory, London North Genomic Laboratory Hub, Great Ormond Street Hospital for Children National Health Service Foundation Trust, Levels 4-6 Barclay House 37, Queen Square, London WC1N 3BH, UK; [email protected] * Correspondence: [email protected]; Tel.: +44-2381204172; Fax: +44-020-74726476 Received: 11 February 2020; Accepted: 29 February 2020; Published: 5 March 2020 Abstract: Electrolyte homeostasis is maintained by the kidney through a complex transport function mostly performed by specialized proteins distributed along the renal tubules. Pathogenic variants in the genes encoding these proteins impair this function and have consequences on the whole organism. Establishing a genetic diagnosis in patients with renal tubular dysfunction is a challenging task given the genetic and phenotypic heterogeneity, functional characteristics of the genes involved and the number of yet unknown causes. Part of these difficulties can be overcome by gathering large patient cohorts and applying high-throughput sequencing techniques combined with experimental work to prove functional impact. This approach has led to the identification of a number of genes but also generated controversies about proper interpretation of variants. In this article, we will highlight these challenges and controversies. Keywords: inherited tubulopathies; next generation sequencing; genetic heterogeneity; variant classification. 1. Introduction Mutations in genes that encode transporter proteins in the renal tubule alter kidney capacity to maintain homeostasis and cause diseases recognized under the generic name of inherited tubulopathies.
  • Inhibition of ROMK Channels by Low Extracellular K and Oxidative Stress

    Inhibition of ROMK Channels by Low Extracellular K and Oxidative Stress

    Am J Physiol Renal Physiol 305: F208–F215, 2013. First published May 15, 2013; doi:10.1152/ajprenal.00185.2013. Inhibition of ROMK channels by low extracellular Kϩ and oxidative stress Gustavo Frindt,1 Hui Li,2 Henry Sackin,2 and Lawrence G. Palmer1 1Department of Physiology and Biophysics, Weill-Cornell Medical College, New York, New York; and 2Department of Physiology and Biophysics, The Chicago Medical School, Rosalind Franklin University, North Chicago, Illinois Submitted 2 April 2013; accepted in final form 8 May 2013 Frindt G, Li H, Sackin H, Palmer LG. Inhibition of ROMK may be essential for preventing Kϩ secretion and minimizing channels by low extracellular Kϩ and oxidative stress. Am J Physiol K losses. Renal Physiol 305: F208–F215, 2013. First published May 15, 2013; Measurements of ROMK activity in heterologous expression doi:10.1152/ajprenal.00185.2013.—We tested the hypothesis that low systems indicate that the channels are sensitive to changes in luminal Kϩ inhibits the activity of ROMK channels in the rat cortical ϩ ϩ ϩ the extracellular K concentration ([K ]o); decreases in [K ]o collecting duct. Whole-cell voltage-clamp measurements of the com- downregulate the channels (7, 28, 29, 31). One aspect of this Downloaded from ponent of outward Kϩ current inhibited by the bee toxin Tertiapin-Q ϩ response is a shift in the dependence of channel activity on (ISK) showed that reducing the bath concentration ([K ]o)to1mM intracellular pH, with low [Kϩ] moving the titration curve for resulted in a decline of current over 2 min compared with that o ϩ inhibition of the channels toward a higher, more physiological observed at 10 mM [K ]o.
  • Ion Channels 3 1

    Ion Channels 3 1

    r r r Cell Signalling Biology Michael J. Berridge Module 3 Ion Channels 3 1 Module 3 Ion Channels Synopsis Ion channels have two main signalling functions: either they can generate second messengers or they can function as effectors by responding to such messengers. Their role in signal generation is mainly centred on the Ca2 + signalling pathway, which has a large number of Ca2+ entry channels and internal Ca2+ release channels, both of which contribute to the generation of Ca2 + signals. Ion channels are also important effectors in that they mediate the action of different intracellular signalling pathways. There are a large number of K+ channels and many of these function in different + aspects of cell signalling. The voltage-dependent K (KV) channels regulate membrane potential and + excitability. The inward rectifier K (Kir) channel family has a number of important groups of channels + + such as the G protein-gated inward rectifier K (GIRK) channels and the ATP-sensitive K (KATP) + + channels. The two-pore domain K (K2P) channels are responsible for the large background K current. Some of the actions of Ca2 + are carried out by Ca2+-sensitive K+ channels and Ca2+-sensitive Cl − channels. The latter are members of a large group of chloride channels and transporters with multiple functions. There is a large family of ATP-binding cassette (ABC) transporters some of which have a signalling role in that they extrude signalling components from the cell. One of the ABC transporters is the cystic − − fibrosis transmembrane conductance regulator (CFTR) that conducts anions (Cl and HCO3 )and contributes to the osmotic gradient for the parallel flow of water in various transporting epithelia.
  • Ion Channels

    Ion Channels

    UC Davis UC Davis Previously Published Works Title THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. Permalink https://escholarship.org/uc/item/1442g5hg Journal British journal of pharmacology, 176 Suppl 1(S1) ISSN 0007-1188 Authors Alexander, Stephen PH Mathie, Alistair Peters, John A et al. Publication Date 2019-12-01 DOI 10.1111/bph.14749 License https://creativecommons.org/licenses/by/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: Ion channels. British Journal of Pharmacology (2019) 176, S142–S228 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels Stephen PH Alexander1 , Alistair Mathie2 ,JohnAPeters3 , Emma L Veale2 , Jörg Striessnig4 , Eamonn Kelly5, Jane F Armstrong6 , Elena Faccenda6 ,SimonDHarding6 ,AdamJPawson6 , Joanna L Sharman6 , Christopher Southan6 , Jamie A Davies6 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 3Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 4Pharmacology and Toxicology, Institute of Pharmacy, University of Innsbruck, A-6020 Innsbruck, Austria 5School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 6Centre for Discovery Brain Science, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties.
  • Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery

    Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery

    fphar-07-00121 May 7, 2016 Time: 11:45 # 1 REVIEW published: 10 May 2016 doi: 10.3389/fphar.2016.00121 Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery Paola Imbrici1*, Antonella Liantonio1, Giulia M. Camerino1, Michela De Bellis1, Claudia Camerino2, Antonietta Mele1, Arcangela Giustino3, Sabata Pierno1, Annamaria De Luca1, Domenico Tricarico1, Jean-Francois Desaphy3 and Diana Conte1 1 Department of Pharmacy – Drug Sciences, University of Bari “Aldo Moro”, Bari, Italy, 2 Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari “Aldo Moro”, Bari, Italy, 3 Department of Biomedical Sciences and Human Oncology, University of Bari “Aldo Moro”, Bari, Italy In the human genome more than 400 genes encode ion channels, which are transmembrane proteins mediating ion fluxes across membranes. Being expressed in all cell types, they are involved in almost all physiological processes, including sense perception, neurotransmission, muscle contraction, secretion, immune response, cell proliferation, and differentiation. Due to the widespread tissue distribution of ion channels and their physiological functions, mutations in genes encoding ion channel subunits, or their interacting proteins, are responsible for inherited ion channelopathies. These diseases can range from common to very rare disorders and their severity can be mild, Edited by: disabling, or life-threatening. In spite of this, ion channels are the primary target of only Maria Cristina D’Adamo, University of Perugia, Italy about 5% of the marketed drugs suggesting their potential in drug discovery. The current Reviewed by: review summarizes the therapeutic management of the principal ion channelopathies Mirko Baruscotti, of central and peripheral nervous system, heart, kidney, bone, skeletal muscle and University of Milano, Italy Adrien Moreau, pancreas, resulting from mutations in calcium, sodium, potassium, and chloride ion Institut Neuromyogene – École channels.
  • Mclean, Chelsea.Pdf

    Mclean, Chelsea.Pdf

    COMPUTATIONAL PREDICTION AND EXPERIMENTAL VALIDATION OF NOVEL MOUSE IMPRINTED GENES A Dissertation Presented to the Faculty of the Graduate School of Cornell University In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy by Chelsea Marie McLean August 2009 © 2009 Chelsea Marie McLean COMPUTATIONAL PREDICTION AND EXPERIMENTAL VALIDATION OF NOVEL MOUSE IMPRINTED GENES Chelsea Marie McLean, Ph.D. Cornell University 2009 Epigenetic modifications, including DNA methylation and covalent modifications to histone tails, are major contributors to the regulation of gene expression. These changes are reversible, yet can be stably inherited, and may last for multiple generations without change to the underlying DNA sequence. Genomic imprinting results in expression from one of the two parental alleles and is one example of epigenetic control of gene expression. So far, 60 to 100 imprinted genes have been identified in the human and mouse genomes, respectively. Identification of additional imprinted genes has become increasingly important with the realization that imprinting defects are associated with complex disorders ranging from obesity to diabetes and behavioral disorders. Despite the importance imprinted genes play in human health, few studies have undertaken genome-wide searches for new imprinted genes. These have used empirical approaches, with some success. However, computational prediction of novel imprinted genes has recently come to the forefront. I have developed generalized linear models using data on a variety of sequence and epigenetic features within a training set of known imprinted genes. The resulting models were used to predict novel imprinted genes in the mouse genome. After imposing a stringency threshold, I compiled an initial candidate list of 155 genes.
  • Pflugers Final

    Pflugers Final

    CORE Metadata, citation and similar papers at core.ac.uk Provided by Serveur académique lausannois A comprehensive analysis of gene expression profiles in distal parts of the mouse renal tubule. Sylvain Pradervand2, Annie Mercier Zuber1, Gabriel Centeno1, Olivier Bonny1,3,4 and Dmitri Firsov1,4 1 - Department of Pharmacology and Toxicology, University of Lausanne, 1005 Lausanne, Switzerland 2 - DNA Array Facility, University of Lausanne, 1015 Lausanne, Switzerland 3 - Service of Nephrology, Lausanne University Hospital, 1005 Lausanne, Switzerland 4 – these two authors have equally contributed to the study to whom correspondence should be addressed: Dmitri FIRSOV Department of Pharmacology and Toxicology, University of Lausanne, 27 rue du Bugnon, 1005 Lausanne, Switzerland Phone: ++ 41-216925406 Fax: ++ 41-216925355 e-mail: [email protected] and Olivier BONNY Department of Pharmacology and Toxicology, University of Lausanne, 27 rue du Bugnon, 1005 Lausanne, Switzerland Phone: ++ 41-216925417 Fax: ++ 41-216925355 e-mail: [email protected] 1 Abstract The distal parts of the renal tubule play a critical role in maintaining homeostasis of extracellular fluids. In this review, we present an in-depth analysis of microarray-based gene expression profiles available for microdissected mouse distal nephron segments, i.e., the distal convoluted tubule (DCT) and the connecting tubule (CNT), and for the cortical portion of the collecting duct (CCD) (Zuber et al., 2009). Classification of expressed transcripts in 14 major functional gene categories demonstrated that all principal proteins involved in maintaining of salt and water balance are represented by highly abundant transcripts. However, a significant number of transcripts belonging, for instance, to categories of G protein-coupled receptors (GPCR) or serine-threonine kinases exhibit high expression levels but remain unassigned to a specific renal function.
  • Ion Channels Accelerated D1scovery

    Ion Channels Accelerated D1scovery

    Quality Antibodies · Quality Results $-GeneTex Your Expertise Our Antibod1es Ion Channels Accelerated D1scovery --------- www.genetex.com Potassium (K+ ) Sodium (Na+ ) Calcium (Ca2+ ) Ion channels are pore-forming, usually multimeric plasma membrane proteins that can open and close in response to chemical, temperature, or mechanical signals. An open channel allows specific ions to rapid ly traverse the transmembrane passageway a long an electrochemical gradient, generating an electrical signal that is propagated along excitable cells. Ion channels are of immense importance in clinical medicine as they are linked to a broad array of disorders and are targets of an ever-expanding, and commonly prescribed, armamentarium of pharmacologic agents. Nevertheless, there remains a great void in our understanding of ion channel biology, which limits our ability to develop more effective andmo re specific drugs. GeneTex offers an outstanding selection of antibodies to support ion channel research.Please see the highlighted antibodies in this flyer or review our complete list of related products on the GeneTex website. Highlighted products HCNl antibody (GTX131334} DPP6 antibody (GTX133338} IP3 Receptor I antibody (GTX133104} (...___ ___w _w _w_ ._G_e_n_e_T_e_x_._c_o_m_ _____,) ` a n a 匱 。 'ot I: . ·""·,, " . 鼴 丶•' · ,' , `> ,,, 丶 B -- ,:: ·-- o .i :' T. 、 冨 ,. \\.◄ .•}' r<• .. , -·•Jt.<_,,,, . ◄ · ◄ / .Jj -~~ 盆;i . '. ., CACNB4 (GTX100202) VGluTl antibody (GTX133148) P2X7一 antibody (GTX104288) Cavl.2 antibody (GTX54754) Cav2.1 antibody (GTX54753)
  • Chloride Channelopathies Rosa Planells-Cases, Thomas J

    Chloride Channelopathies Rosa Planells-Cases, Thomas J

    Chloride channelopathies Rosa Planells-Cases, Thomas J. Jentsch To cite this version: Rosa Planells-Cases, Thomas J. Jentsch. Chloride channelopathies. Biochimica et Biophysica Acta - Molecular Basis of Disease, Elsevier, 2009, 1792 (3), pp.173. 10.1016/j.bbadis.2009.02.002. hal- 00501604 HAL Id: hal-00501604 https://hal.archives-ouvertes.fr/hal-00501604 Submitted on 12 Jul 2010 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. ÔØ ÅÒÙ×Ö ÔØ Chloride channelopathies Rosa Planells-Cases, Thomas J. Jentsch PII: S0925-4439(09)00036-2 DOI: doi:10.1016/j.bbadis.2009.02.002 Reference: BBADIS 62931 To appear in: BBA - Molecular Basis of Disease Received date: 23 December 2008 Revised date: 1 February 2009 Accepted date: 3 February 2009 Please cite this article as: Rosa Planells-Cases, Thomas J. Jentsch, Chloride chan- nelopathies, BBA - Molecular Basis of Disease (2009), doi:10.1016/j.bbadis.2009.02.002 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form.